The present invention relates to novel quinazolin-4-one derivatives of the formula
I, as defined in the specification, pharmaceutical compositions containing such
compounds the use of such compounds to treat neurodegenerative, psychotropic, and
drug and alcohol induced central and peripheral nervous system disorders.
